[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@TaxiBiotech TaxiBiotech
TaxiBiotech posts on X about $ipn, h1, stocks, drops the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Engagements: XXX #
- X Week XXX +46%
- X Month XXXXX -XX%
- X Months XXXXXX +78%
- X Year XXXXXXX +6,241%
Mentions: X #
- X Week X -XX%
- X Month XX -XX%
- X Months XXX +84%
- X Year XXX +3,140%
Followers: XXX #
- X Week XXX +1.60%
- X Month XXX +2.40%
- X Months XXX +266%
CreatorRank: XXXXXXXXX #
Social Influence #
Social category influence stocks XXXX% finance XXXX% social networks XXXX% technology brands XXXX%
Social topic influence $ipn #1, h1 1.55%, stocks 0.78%, drops 0.78%, $rhhby 0.78%, $novartis 0.78%, $prax 0.78%, $cccc 0.78%, $aps 0.78%, $vor XXXX%
Top accounts mentioned or mentioned by @amaymd @goosedata @lxngevitylab @maximusholla @grok @themarketear @zerohedge @stmkrs @ghoutanews @dr_giggles4u
Top assets mentioned Cytokinetics Inc. (CYTK) Cosmos Holdings Inc. (COSM) Novartis AG (NVS) Novo-Nordisk (NVO) GSK plc (GSK)
Top Social Posts #
Top posts by engagements in the last XX hours
"🚨💊 Biotech stocks on the move Heres your daily recap Oct 16: breakthroughs data drops and price swings across the biotech market. 📈 From Roches fast DNA sequencing to Praxis soaring +200% 🎥 👉 Tickers: $RHHBY $NOVARTIS $PRAX $CCCC $APS $VOR $NXTC $SIMC $CYTK $COSM $APLM $ENTX $SNTI $FHTX $CLLS $ANIP $NVCT $LIXT $SEER"
X Link @TaxiBiotech 2025-10-16T15:08Z XXX followers, XXX engagements
"💊 Daily recap of biotech stock news 📈 Featuring: $OMER $NVO Boehringer AimedBio $SCYX $GSK $SPRC $AKTX $BLTE $KEROS $EYPT $GYRE $ARGX $BDSX $ANGP and $MNPR 😅 Oops I forgot the subtitles try the YouTube ones they actually work pretty well 🎬"
X Link @TaxiBiotech 2025-10-15T15:07Z XXX followers, XXX engagements
"$IPN Ipsen H1 total ingresos: 1.82B Beneficio core neto: 508M (+27%) EPS: XXXX IFRS EPS: XXXX Cash: 487.6M 🚀 Suben gua 2025: Grecimiento de ventas +7% Margen operativo XX% 🧬 Pipeline activo: cabometyx (APROBADO) elafibranor tovorafenib fidrisertib IPN10200"
X Link @TaxiBiotech 2025-07-31T09:47Z XXX followers, XX engagements
"📢 $HCM HKEX: XX HUTCHMED will present new clinical data at #ESMO2025 (October 17-21): - FRUSICA-2 (fruquintinib + sintilimab) in advanced renal cell carcinoma - Analyses of FRUSICA-1 in endometrial cancer - Savolitinib in non-small cell lung cancer"
X Link @TaxiBiotech 2025-10-02T08:46Z XXX followers, XXX engagements
"$IPN Ipsen H1 total revenue: 1.82B Core net profit: 508M (+27%) Cash: 487.6M 🚀 2025 guidance raised: Sales growth: +7% Core Op margin: XX% 🧬 Active pipeline: cabometyx (APPROVED) elafibranor tovorafenib fidrisertib IPN10200"
X Link @TaxiBiotech 2025-07-31T09:51Z XXX followers, XXX engagements